is semaglutide a compound drug Troubling Findings in Study of GLP-1 Compounders Some doctors are embracing compounded

Before starting any GLP-1, patients need baseline assessment for thyroid history, pancreatitis risk, kidney function, and medication interactions

Investigational GLP-1 patches use specialised technologies such as microneedles to deliver large peptide molecules across the skin barrier

The peptide binds to GIP and GLP-1 receptors continuously once plasma concentrations reach therapeutic range, which occurs 1224 hours after the first injection and remains elevated for the entire 7-day dosing interval

Rushing from reconstitution to injection can result in uneven concentration if the powder has not completely dissolved